Kolexia
Sosner Philippe
Cardiologie
Hôpital Hôtel-Dieu Paris
Paris, France
134 Activités
936 Followers

Scientifique
Digital
Production scientifique
Activités par an
Expertise
Sujets de recherche
{{person.topmesh1.name}} Hypertension artérielle Diabète de type 2 Néphropathies diabétiques Diabète Hypertrophie ventriculaire gauche Infarctus du myocarde Obésité Albuminurie Défaillance cardiaque

Industries

Boston Scientific
1 collaboration(s)
Dernière en 2021
{{person.topindus2.name}}
{{person.topindus2.tot}} collaboration(s)
Dernière en {{person.topindus2.last}}
{{person.topindus3.name}}
{{person.topindus3.tot}} collaboration(s)
Dernière en {{person.topindus3.last}}
{{person.topindus4.name}}
{{person.topindus4.tot}} collaboration(s)
Dernière en {{person.topindus4.last}}

Dernières activités

Relationship between accessory renal arteries and resistant hypertension: A cohort study.
Journal de medecine vasculaire   05 avril 2023
Systematic cardiac screening before returning to play in athletes after SARS-CoV-2 infection
JESFC 2023   01 janvier 2023
Cardiac screening before returning to elite sport after SARS-CoV-2 infection.
Archives of cardiovascular diseases   29 septembre 2022
SESAME: Study of the Determinants Associated With Sustained Changes in Physical Activity Behaviors, and Their Effects on the Prevention and Treatment of Chronic Diseases, in Individuals Enrolled in an Adapted Physical Activity Program
Essai Clinique (Mon Stade Sports Medicine Centre)   06 avril 2022
Activité physique : indications et contre-indications selon le type d’hypertension artérielle
Archives des maladies du coeur et des vaisseaux. Pratique   01 avril 2022
Acute Effect of a Simultaneous Exercise and Cognitive Task on Executive Functions and Prefrontal Cortex Oxygenation in Healthy Older Adults.
Brain sciences   28 mars 2022
Hypertension in Children and Adolescents: A Position Statement From a Panel of Multidisciplinary Experts Coordinated by the French Society of Hypertension.
Frontiers in pediatrics   07 juillet 2021
A novel personalized approach to cardiovascular prevention: The VIVOPTIM programme.
Archives of cardiovascular diseases   01 octobre 2020
Target blood pressure and cardiovascular risk.
Journal of thoracic disease   29 septembre 2020
Serum tenascin-C is independently associated with increased major adverse cardiovascular events and death in individuals with type 2 diabetes: a French prospective cohort.
Diabetologia   10 février 2020